Related Experiment Video
Updated: Apr 26, 2026
09:03
The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
21.6K
Hepatitis mouse models: from acute-to-chronic autoimmune hepatitis
Muhammed Yüksel1, Debby Laukens, Femke Heindryckx
1Department of Hepatology and Gastroenterology, Ghent University, Ghent, Belgium; Department of Endocrinology, Yale School of Medicine, New Haven, CT, USA.
International Journal of Experimental Pathology
|August 13, 2014
Summary
Autoimmune hepatitis (AIH) involves liver inflammation, autoantibodies, and regulatory T-cell (Tregs) dysfunction. Animal models help study AIH development and potential treatments by mimicking human pathology.
Area of Science:
- Immunology
- Hepatology
- Autoimmunity
Background:
- Autoimmune hepatitis (AIH) is a chronic liver disease characterized by inflammation, autoantibodies, and regulatory T-cell (Tregs) dysfunction.
- AIH presents with diverse clinical courses, influenced by genetic and environmental factors.
- Understanding AIH pathophysiology is crucial for developing effective treatments.
Purpose of the Study:
- To explore the development of autoimmune hepatitis (AIH) using a mouse model.
- To investigate the role of regulatory T-cells (Tregs) in maintaining liver immune homeostasis.
- To identify key autoantigens and mechanisms involved in experimental AIH.
Main Methods:
- Development of experimental autoimmune hepatitis (AIH) in C57BL/6 mice.
- Immunization with specific liver autoantigens (CYP2D6/FTCD or IL-4R).
- Assessment of liver pathology and immune responses, focusing on Tregs and immune homeostasis.
Main Results:
- Experimental AIH was successfully induced in C57BL/6 mice, mimicking human disease characteristics.
- Breaking liver tolerance is achievable, but maintaining chronic inflammation is challenging due to regulatory mechanisms.
- Tregs play a critical role in regulating immune responses in experimental AIH.
Conclusions:
- Experimental AIH models in mice, particularly C57BL/6, are valuable for studying human AIH.
- Understanding the balance between tolerance breakdown and immune regulation is key to AIH pathogenesis.
- Further research into Tregs and autoantigens may reveal new therapeutic targets for AIH.
